Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
AXIM BIOTECHNOLOGIES, INC.Listing on record | Buy | n/a (No price was disclosed in the filing) | conv 39First in 12mo | SEC | |
AXIM BIOTECHNOLOGIES, INC.Listing on record | AwardD (derivative) | $1.2T | SEC | ||
AXIM BIOTECHNOLOGIES, INC.Listing on record | Buy | $115.8K | conv 27First in 12mo | SEC |